SG11202104849UA - A peripheral blood mirna marker for diagnosis of non-small cell lung cancer - Google Patents
A peripheral blood mirna marker for diagnosis of non-small cell lung cancerInfo
- Publication number
- SG11202104849UA SG11202104849UA SG11202104849UA SG11202104849UA SG11202104849UA SG 11202104849U A SG11202104849U A SG 11202104849UA SG 11202104849U A SG11202104849U A SG 11202104849UA SG 11202104849U A SG11202104849U A SG 11202104849UA SG 11202104849U A SG11202104849U A SG 11202104849UA
- Authority
- SG
- Singapore
- Prior art keywords
- diagnosis
- lung cancer
- small cell
- peripheral blood
- cell lung
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811336972.2A CN109207599A (en) | 2018-11-12 | 2018-11-12 | A kind of peripheral blood miRNA marker for Diagnosis of Non-Small Cell Lung |
| PCT/CN2019/117176 WO2020098607A1 (en) | 2018-11-12 | 2019-11-11 | A peripheral blood miRNA marker for diagnosis of non-small cell lung cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202104849UA true SG11202104849UA (en) | 2021-06-29 |
Family
ID=64995188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202104849UA SG11202104849UA (en) | 2018-11-12 | 2019-11-11 | A peripheral blood mirna marker for diagnosis of non-small cell lung cancer |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230287504A1 (en) |
| EP (1) | EP3880849A4 (en) |
| JP (1) | JP2022507252A (en) |
| KR (1) | KR20210104037A (en) |
| CN (3) | CN109207599A (en) |
| AU (1) | AU2019378289A1 (en) |
| PH (1) | PH12021551087A1 (en) |
| SG (1) | SG11202104849UA (en) |
| WO (1) | WO2020098607A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109207599A (en) * | 2018-11-12 | 2019-01-15 | 觅瑞（杭州）生物科技有限公司 | A kind of peripheral blood miRNA marker for Diagnosis of Non-Small Cell Lung |
| CN111239389A (en) * | 2020-01-20 | 2020-06-05 | 复旦大学附属中山医院 | Autoantibody marker for distinguishing liver cell liver cancer from normal person and screening method thereof |
| CN112063716A (en) * | 2020-09-09 | 2020-12-11 | 南通大学 | Detection kit for evaluating drug resistance and metastasis occurrence risk of lung cancer |
| CN112695095A (en) * | 2021-01-11 | 2021-04-23 | 中国医科大学 | Peripheral blood miRNA lung cancer diagnosis marker combination and detection kit thereof |
| CN114606319A (en) * | 2021-04-16 | 2022-06-10 | 博尔诚（北京）科技有限公司 | Marker, kit and system for detecting lung cancer |
| CN113862355A (en) * | 2021-09-27 | 2021-12-31 | 苏州健雄职业技术学院 | Group of miRNA biomarkers related to lung cancer and application thereof |
| CN115125304B (en) * | 2022-06-29 | 2023-07-04 | 宁波大学 | CERNA regulation network for early diagnosis or detection of non-small cell lung cancer and application thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2633674A1 (en) * | 2006-01-05 | 2007-07-19 | The Ohio State University Research Foundation | Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer |
| CN101684489A (en) * | 2008-09-25 | 2010-03-31 | 中国科学院上海生命科学研究院 | Diagnosis marker of lung cancer |
| EP2336353A1 (en) * | 2009-12-17 | 2011-06-22 | febit holding GmbH | miRNA fingerprints in the diagnosis of diseases |
| CN101638656B (en) * | 2009-08-28 | 2011-05-11 | 南京医科大学 | Blood serum/blood plasma miRNA marker related to non-small cell lung cancer (SCLC) prognosis and application thereof |
| CN101921759B (en) * | 2010-09-08 | 2013-05-29 | 南京医科大学 | Serum/plasma miRNA serum marker related to cervical carcinoma and precancerous lesions thereof and application thereof |
| CN102321760A (en) * | 2011-08-26 | 2012-01-18 | 泸州医学院附属医院 | Non-small cell lung cancer (NSCLC) marker and its application |
| CN102965441A (en) * | 2012-12-06 | 2013-03-13 | 苏州市思玛特电力科技有限公司 | Application of micro RNA (Ribonucleic Acid) gene miR-1291 on predication of prognosis of breast cancer |
| US11053545B2 (en) * | 2015-09-08 | 2021-07-06 | The Translational Genomics Research Institute | Biomarkers and methods of diagnosing and prognosing mild traumatic brain injuries |
| CN109207599A (en) * | 2018-11-12 | 2019-01-15 | 觅瑞（杭州）生物科技有限公司 | A kind of peripheral blood miRNA marker for Diagnosis of Non-Small Cell Lung |
-
2018
- 2018-11-12 CN CN201811336972.2A patent/CN109207599A/en active Pending
-
2019
- 2019-11-11 CN CN201911095703.6A patent/CN110656181B/en active Active
- 2019-11-11 US US17/293,382 patent/US20230287504A1/en active Pending
- 2019-11-11 KR KR1020217016762A patent/KR20210104037A/en active Search and Examination
- 2019-11-11 JP JP2021525727A patent/JP2022507252A/en active Pending
- 2019-11-11 CN CN202310870797.XA patent/CN117867105A/en active Pending
- 2019-11-11 WO PCT/CN2019/117176 patent/WO2020098607A1/en unknown
- 2019-11-11 AU AU2019378289A patent/AU2019378289A1/en active Pending
- 2019-11-11 EP EP19885678.3A patent/EP3880849A4/en active Pending
- 2019-11-11 SG SG11202104849UA patent/SG11202104849UA/en unknown
-
2021
- 2021-05-11 PH PH12021551087A patent/PH12021551087A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20230287504A1 (en) | 2023-09-14 |
| CN109207599A (en) | 2019-01-15 |
| CN117867105A (en) | 2024-04-12 |
| CN110656181A (en) | 2020-01-07 |
| EP3880849A4 (en) | 2022-08-24 |
| CN110656181B (en) | 2024-03-05 |
| AU2019378289A1 (en) | 2021-06-10 |
| WO2020098607A1 (en) | 2020-05-22 |
| JP2022507252A (en) | 2022-01-18 |
| KR20210104037A (en) | 2021-08-24 |
| EP3880849A1 (en) | 2021-09-22 |
| PH12021551087A1 (en) | 2021-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202104849UA (en) | A peripheral blood mirna marker for diagnosis of non-small cell lung cancer | |
| HK1248141A1 (en) | Methods of conditioning patients for t cell therapy | |
| EP3180075A4 (en) | Integrated electromyographic clinician programmer for use with an implantable neurostimulator | |
| EP3177739A4 (en) | Microrna biomarker for the diagnosis of gastric cancer | |
| EP3359689A4 (en) | Use of a genetic signature diagnostically to evaluate treatment strategies for prostate cancer | |
| EP3128917A4 (en) | System and method for assessing a cancer status of biological tissue | |
| IL270717A (en) | Biomarkers for diagnosis of lung cancer | |
| EP3393372A4 (en) | System and method for increasing a cross-sectional area of a body lumen | |
| EP3597733A4 (en) | Three-dimensional culture of primary cancer cells using tumor tissue | |
| EP3221003A4 (en) | Therapy system for transcutaneous in-vivo tissue engineering | |
| EP3365063A4 (en) | Method of scoring a sample comprising tumor tissue | |
| HK1253082A1 (en) | Method of diagnosis of breast cancer | |
| HK1257345A1 (en) | Method for manufacturing tissue/organ by using blood cells | |
| IL289348A (en) | Novel diagnostic marker for pancreatic cancer | |
| ZA202107342B (en) | Chiauranib for treatment of small cell lung cancer | |
| EP3318632B8 (en) | Marker for heterogeneity of cancer tissue, and use thereof | |
| GB201814350D0 (en) | Diagnosis of cancer | |
| IL246580A0 (en) | Lung cancer diagnostic methods using mirna ratios | |
| EP3607066A4 (en) | Methods of detecting lung cancer | |
| PL3580567T3 (en) | In vitro method for the diagnosis of lung cancer | |
| ZA202202930B (en) | Diagnostic chromosome marker | |
| GB201702392D0 (en) | Methods for cancer diagnosis using a gene expression signature | |
| EP2879712A4 (en) | Histological markers for identifying non-small cell lung carcinoma patients for treatment with an anti-egfr drug | |
| IL248473A0 (en) | Biological markers for identifying patients for treatment with abiraterone acetate | |
| HK1218939A1 (en) | Drug selection for non-small cell lung cancer therapy |